TIDMTEK
Tekcapital plc
14 October 2021
14 October 2021
Tekcapital Plc
("Tekcapital", the "Company" or "the Group")
Portfolio Company Update: Salarius, Ltd. ("Salarius")
FDA Releases Voluntary Sodium Reduction Goals for the Food
Industry
Tekcapital Plc (AIM: TEK), (OTCQB: TEKCF) the UK intellectual
property investment group focused on creating valuable products
from investing in university technology that can improve people's
lives, is very pleased to announce that the U.S. Food and Drug
Administration (FDA) has just released voluntary sodium reduction
goals for the food industry "to provide measurable voluntary
short-term (2.5-year) goals for sodium content in commercially
processed, packaged, and prepared foods to reduce excess population
sodium intake." ([i])
Dr. Jennifer Ashton, ABC News chief medical correspondent said
"the news from acting FDA Commissioner Janet Woodcock and Susan T.
Mayne, director of the FDA's Center for Food Safety and Applied
Nutrition, could be the biggest, most important intervention in a
generation for public health."[ii]
This is a significant milestone for Salarius for the following
reasons:
-- We believe the FDA guidelines will encourage snack food
manufactures to reduce the sodium levels in their products across
the board;
-- Salarius anticipates this should have a positive impact on
both B2B sales of MicroSalt(R) and retail sales of SaltMe!
crisps;
-- MicroSalt(R) as a brand could be viewed as a timely,
nationwide solution, to help food companies meet these guidelines
without sacrificing the full-flavour of their snack foods, which is
key to their successful on-going sales.
MicroSalt aims to revolutionize the food industry with its
patented sodium microparticle, that delivers the full-flavour
experience of salt with roughly half the sodium. MicroSalt's salt
particles are approximately 100 times smaller than regular table
salt, allowing them to rapidly dissolve, producing a large
sensation of saltiness. MicroSalt(R) is all-natural, non-GMO, and
Kosher.
"We're very excited to see the FDA take a leadership role in
encouraging the food industry to embark on meaningful sodium
reduction programs for their products," said Victor Hugo
Manzanilla, CEO of MicroSalt. "This is a major milestone for the
country, and we are ready to partner with food manufacturers to
help them comply with the new guidelines whilst maintaining the
full-flavour of their snacks."
About Salarius Ltd.
Salarius, is the developer and manufacturer of a proprietary
low-sodium salt called MicroSalt(R). We are passionate about
improving peoples' lives with better-for-you snacks by taking the
lead in the industry by providing the best low-sodium salt
solution, based on the mechanical transformation of the salt
particle itself. This solution is the only one that delivers real
salt flavor because it is salt. Our new patented technology
produces salt crystals that are approximately one hundred times
smaller than typical table salt, delivering a powerful saltiness as
the micro-grains dissolve in the mouth, with approximately 50% less
sodium consumption. Additionally, the ultra-small particle size
enhances product adhesion, which reduces waste and provides
improved flavor consistency. MicroSalt(R) and SaltMe(R) are
registered trademarks of MicroSalt Inc.
To learn more about MicroSalt please visit https://Salarius.co/
.
To learn more about SaltMe! snacks please visit https://saltme.com/ .
Tekcapital owns 97.2% of the share capital of Salarius Ltd. and
87.1% of the share capital of MicroSalt Inc., its U.S.
subsidiary.
About Tekcapital plc
Tekcapital creates value from investing in new,
university-developed discoveries that can enhance people's lives
and provides a range of technology transfer services to help
organisations evaluate and commercialise new technologies.
Tekcapital is quoted on the AIM market of the London Stock Exchange
(AIM: symbol TEK) and is headquartered in the UK. For more
information, please visit www.tekcapital.com .
LEI: 213800GOJTOV19FIFZ85
For further information, please contact:
Tekcapital Plc Via Flagstaff IR
Clifford M. Gross, Ph.D.
SP Angel Corporate Finance LLP (Nominated
Adviser and Broker) +44 (0) 20 3470 0470
Richard Morrison / Charlie Bouverat (Corporate
Finance)
Rob Rees (Corporate Broking)
Flagstaff Strategic and Investor Communications +44 (0)207 129
1474
Tim Thompson/Andrea Seymour/Fergus Mellon
This press release is for informational purposes only. The
information herein does not constitute investment advice nor an
offer to invest and may contain statements related to our future
business and financial performance and future events or
developments involving Salarius that may constitute forward-looking
statements. These statements may be identified by words such as
"expect," "look forward to," "anticipate" "intend," "plan,"
"believe," "seek," "estimate," "will," "project" or words of
similar meaning. We may also make forward-looking statements in
other reports, in presentations, in material delivered to
customers, stakeholders and in press releases. In addition, our
representatives may from time to time make oral forward-looking
statements. Such statements may be based on the current
expectations and certain assumptions of Salarius' and/or
Tekcapital's management. Please note that these are subject to a
number of risks, uncertainties and factors, including, but not
limited to those described in various disclosures. Should one or
more of these risks or uncertainties materialize, or should
underlying expectations not occur or assumptions prove incorrect,
actual results, performance or achievements of Salarius or
Tekcapital may vary materially from those described explicitly or
implicitly in the relevant forward-looking statement. Neither
Salarius nor Tekcapital intends, nor assumes any obligation, to
update or revise these forward-looking statements in light of
developments which differ from those anticipated.
[i]
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-industry-voluntary-sodium-reduction-goals
[ii]
https://www.goodmorningamerica.com/food/story/fda-recommends-restaurants-food-manufacturers-cut-back-salt-80554477
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAEAKEDFDPFFFA
(END) Dow Jones Newswires
October 14, 2021 02:00 ET (06:00 GMT)
Tekcapital (LSE:TEK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Tekcapital (LSE:TEK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
